MedPath

Effect of Cladosiphon okamuranus Fucoidan Containing Drink on Improvement of Defecation in Healthy Subjects with Mild Constipation.

Not Applicable
Conditions
People tend to be constipated
Registration Number
JPRN-UMIN000028362
Lead Sponsor
SOUTH PRODUCT Co., Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
66
Inclusion Criteria

Not provided

Exclusion Criteria

People who meet any of the following conditions will be excluded. 1.Who regularly use intestinal drugs and laxative (including strong laxatives and enema) 2.Who can not stop intake the health food to relive constipation (including Food for Specified Health Uses (FOSHU)) during the screening period. 3.Who use medicine such as antibiotics that affect digestion and absorption. 4.Who can not stop intake food containing viable bacteria such as Lactic acid bacteria, Bifidobacteria, Natto bacteria and/or enhanced with oligosaccharide, dietary fiber and/or the health food to relive constipation (including Food for Specified Health Uses (FOSHU)) and/or containing a large amount of sugar alcohol during the screening period. 5.Who have allergic to food. 6.Who have serious diseases requiring an urgent treatment, or who accept severe complication. 7.Who has a medical history of diseases or surgery affecting digestion, absorption and bowel movement (except for appendicectomy). 8.Who are judged unsuitable for this study based on subject questionnaire. 9.Who is pregnant or willing to be pregnant or brest-feeding during this study. 10.Who has a current or history of drug dependence and/or alcoholism. 11.Who are participated in another clinical trial that intake/apply any of food, drug, and cosmetics, or willing to be that. 12.Who are judged unsuitable for this study by test responsibility doctor.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Defecation frequency and days of defecation and amount of defecation will be measured. The change will be compared with placebo-controlled groups.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath